Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-000360
Filing Date
2021-01-05
Accepted
2021-01-05 16:15:07
Documents
2
Period of Report
2021-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1600
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4065
  Complete submission text file 0000899243-21-000360.txt   7179
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BUILDING #34 BOSTON MA 02129
Business Address
Shukla Sath (Reporting) CIK: 0001782817 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38266 | Film No.: 21505645